Product analysis
Alpha-GPC 300 mg may support selected attention tasks, but the findings are preliminary and tied to particular preparations.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality20
The Alpha-GPC preparation is not specified, leaving its form quality unclear. The declared amount cannot by itself establish equivalence with a particular active preparation.
Ingredient Transparency63
The Alpha-GPC amount is disclosed. Missing preparation details make comparison with specific active materials less precise.
Value For Money70
Alpha-GPC offers moderate value for the declared amount. The unspecified preparation makes comparisons with identified active materials less certain.
Customer Satisfaction77
Customer feedback is positive. The smaller review base gives a less established picture of satisfaction.
Product Focus51
One active ingredient keeps the formula simple. Evidence for attention and related tasks comes from a small acute exercise setting, leaving wider everyday cognitive benefits uncertain.
- Format
Capsule - Container
- 60 Capsule(s)
- Per serving
- $0.52
- Customer rating
- 4.6 · 703 ratings
Goals
Alpha-GPC supplies choline related to acetylcholine signalling, which is involved in attention and memory. The 300 mg serving provides a partial amount relative to the supplied comparison, with limited preparation-specific attention evidence.
How this product is rated for Brain Health
Ingredient fit74
Goal fit
Dose adequacy
Pathways10
Depth
Breadth
Evidence35
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
Alpha-GPC connects with acetylcholine signalling and preliminary findings on selected attention and executive tasks. The 300 mg serving is near the lower active amount tested, but an unqualified material declaration cannot be assumed to match that active preparation. Evidence is limited to a small acute exercise-related setting.
How this product is rated for Cognitive Support
Ingredient fit91
Goal fit
Dose adequacy
Pathways17
Depth
Breadth
Evidence28
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Alpha Glycerylphosphorylcholine | 300 mg |
How this ingredient is rated
Active Ingredient Quality & Bioavailability40
Patented/Branded Form and Source
Dose, Safety & Label Transparency80
Active Alpha-GPC Dosage
Label Transparency & Yield Disclosure
Value70
Price per 300mg Active Alpha-GPC
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Activity of Choline Alphoscerate on Adult-Onset Cognitive Dysfunctions: A Systematic Review and Meta-Analysis.
- Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized controlled and open-label observation trial.
- Effects of choline alfoscerate on cognitive function and quality of life in type 2 diabetes: A double-blind, randomized, placebo-controlled trial.
- Acute Alpha-Glycerylphosphorylcholine Supplementation Enhances Cognitive Performance in Healthy Men.
- Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial.
- [Gliatilin in the Treatment of Cognitive Impairments Not Reaching the Level of Dementia: Meta-Analysis and Systematic Review].
- Vertical Association Between Dietary Total Choline and L-alpha-glycerylphosphorylcholine and the Cognitive Function in Chinese Adults Aged over 55, Result from China Health and Nutrition Survey 1997-2018.
- Treatment of dementia with neurotransmission modulation.